Abstract
Y-90 radioembolization is an increasingly utilized treatment for both primary and metastatic malignancy in the liver. Understanding the biophysical properties, dosing concerns, and imaging appearance of this treatment is important for interventional radiologists and nuclear medicine physicians to provide important therapy. Y-90 radioembolization is efficacious and safe, although the possibility of complications does exist. This article provides a comprehensive in-depth discussion about the indications for Y-90 radioembolization, reviews the role of pre-procedural angiography and MAA scans, illustrates different dosing techniques, compares and contrasts resin and glass microspheres, and confers potential complications.
- Oncology: GI
- Oncology: Liver
- Radiation Therapy Planning
- Hepatocellular Carcinoma
- MAA
- Metastatic Colorectal Cancer
- Radiation Segmentectomy
- Y90
Footnotes
Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: http://jnm.snmjournals.org/site/misc/permission.xhtml.
- Copyright © 2018 by the Society of Nuclear Medicine and Molecular Imaging, Inc.